Sharmini Premananthan, MD

Internal Medicine PGY-1 @TuftsMedicalCtr | MD @UCRSoM | BS @JohnsHopkins

[Sharmini Premananthan, MD @SharminiPrem]

Would never have been possible without the tremendous support and guidance of my all-star @CedarsSinai @SmidtHeart team!!! To @KevinQ_Chen, @malas_jad, Dr. Esmailian, @DrBowdish, @DominickMegnaMD, @pacman8it, and @JoChikweMD: thank you all so much!!! #ISHLT2023 🫀🫁

[Kevin (Qiudong) Chen @KevinQ_Chen]

Our MS3 @SharminiPrem gave a FANTASTIC talk on the impact of the 2018 heart allocation policy on the incidence of PGD using data from our single center heart txp registry. So proud!👏🏻👏🏻@ISHLT @ISHLTPres #ISHLT2023

[Roland-Garros @rolandgarros]

The greatest there was.
The greatest there is.
The greatest there ever will be.

#RolandGarros

[Roland-Garros @rolandgarros]

A 🐐 moment.

#RolandGarros

[Rafa Nadal @RafaelNadal]

Merci, @rolandgarros! I will never forget this amazing day! 🥹

[Michelle Kittleson MD PhD @MKIttlesonMD]

A heart transplant patient came to clinic: a thriving medical miracle. He stopped himself in the middle of describing some minor aches and pains and said, "Irritation is the luxury of a healthy person."

Now adopted as one of #kittlesonrules.

[Rafa Nadal @RafaelNadal]

Mil gracias a todos
Many thanks to all
Merci beaucoup à tous
Grazie mille à tutti
谢谢大家
شكرا لكم جميعا
תודה לכולכם
Obrigado a todos
Vielen Dank euch allen
Tack alla
Хвала свима
Gràcies a tots

[Sharmini Premananthan, MD @SharminiPrem]

@usopen Rafael Nadal

[Carter J. Glenn @Carterjglenn]

@ThoracicStudent A great opportunity for applicants to help impact the interview format this cycle and identify preference, bias and areas of improvement. Lets get this out there! @Adham_Ahmed_64 @JohnTreffalls @jayyniles @SharminiPrem

[TSMA @ThoracicStudent]

Calling all 2025 ERAS Cycle I-6 applicants, please complete this survey! We are investigating the interview format preferences for I-6 applicants. This data will help inform the interview format for this cycle and allow for analysis of bias and preference. https://t.co/Ub6h6L9XY6

[Johns Hopkins University @JohnsHopkins]

Beginning in the fall of 2024, Johns Hopkins University will provide tuition-free Medical School for most medical students and expand aid for future nurses and public health pioneers. Learn more: https://t.co/QuBluT7CWo

[JACC Journals @JACCJournals]

📢 Call For Papers: Submit your clinical case to #JACCCaseReports by May 31 for a chance to be featured in the first issue of the new editorial board.

Learn more and submit here: https://t.co/JYd4JhhRLw

@GilbertTangMD @MinnowWalsh #CardioEd #CardioX

[Sharmini Premananthan, MD @SharminiPrem]

Happening NOW! Come join us!!! Scan the QR code in the flyer for the registration link!

[TSMA @ThoracicStudent]

🚨 Join us TONIGHT for the next installment of our Bread and Butter Case Series! Explore Lung Resection: Lobectomy for Lung Cancer 🫁 with @rvanharen from @UCincyMedicine.
Sign up now at https://t.co/obceDXX3m5! #ThoracicSurgery

[TSMA @ThoracicStudent]

Interested in Thoracic Surgery? Join us for the next installment of our Bread and Butter Case Series! 🍞📚 Explore Lung Resection: Lobectomy for Lung Cancer 🫁with @rvanharen from @UCincyMedicine.

Register here! - https://t.co/obceDXX3m5 #ThoracicSurgery

[American College of Cardiology @ACCinTouch]

The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years.

Read more: https://t.co/vmsq7FRdYH

#ACC24

[American College of Cardiology @ACCinTouch]

DanGer Shock: Routine implantation of Impella CP on top of standard care is superior to standard care alone in reducing 6-month mortality among patients presenting w/ #STEMI & cardiogenic shock, despite a higher risk of complications. 🔗 https://t.co/Z5EE7Y2rOI

#ACC24

[Davide Capodanno @DFCapodanno]

After 10 years to complete it, the DanGer-SHOCK trial showed that the routine use of a microaxial flow pump with standard care in the treatment of patients with STEMI-related cardiogenic shock led to a lower risk of death from any cause at 180 days than standard care alone.

The incidence of a composite of adverse events and a range of adverse outcomes (bleeding, limb ischemia, renal replacement therapy, sepsis) was significantly higher with the use of the microaxial flow pump.

These results of Impella CP are in contrast with those of of IABP in the IABP-SHOCK II trial and venoarterial ECMO in the ECLS-SHOCK trial. Is this because of the device, or because of better patient selection than in prior trials? #ACC24

https://t.co/1VnRl3bdYu

[NEJM @NEJM]

Presented today at #ACC24:

In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: https://t.co/3625asvzu8

[TSMA @ThoracicStudent]

Come sharpen your skills and join us for the next installment of our Bread and Butter Case Series! 🍞📚 Explore Lung Resection: Lobectomy for Lung Cancer 🫁 with @rvanharen from @UCincyMedicine.

Secure your spot now- https://t.co/obceDXXBbD!
#ThoracicSurgery

[Adham Ahmed, MD @AdhamAhmedMD]

Mark you calendars for next week too! @JeffJacobs215
@UFMedicine @UFSurgery
@GlobalCardiac @cardiackidsfl
@STS_CTsurgery @AATSHQ
@ECTSS_CTsurg @AndrewKalra23

[Johns Hopkins University @JohnsHopkins]

We are excited to announce @MittRomney as the Johns Hopkins University Class of 2024 commencement speaker!

[TSMA @ThoracicStudent]

Have you signed up yet for our LIVE Cardiac Dissection event with @DevenPatelMD? Come learn about the anatomy of the heart and watch a live demonstration of cannulation! Friday, April 5 at 3 PM PST/6 PM EST Sign up - https://t.co/ciMVIBPUwN